MyFinsight
Home
Blog
About
Accounts receivable, net
of allowances of 3...
$271M
(12.92%↑ Y/Y)
Cash and cash
equivalents
$222M
(-56.47%↓ Y/Y)
Inventories
$150M
(0.67%↑ Y/Y)
Other current assets
$54M
(170.00%↑ Y/Y)
Current tax receivable
$16M
(433.33%↑ Y/Y)
Prepaid expenses
$14M
(-50.00%↓ Y/Y)
Total current assets
$725M
(-23.76%↓ Y/Y)
Deferred tax assets
$271M
(0.37%↑ Y/Y)
Property, plant and
equipment, net
$162M
(38.46%↑ Y/Y)
Long-term investments
$27M
(0.00%↑ Y/Y)
Other noncurrent
assets
$24M
(-45.45%↓ Y/Y)
Operating lease right of
use assets, net
$21M
(-40.00%↓ Y/Y)
Goodwill and other
intangible assets, net
$2M
(-71.43%↓ Y/Y)
Total assets
$1,233M
(-15.08%↓ Y/Y)
Accumulated deficit
-$334M
(13.92%↑ Y/Y)
Accumulated other
comprehensive loss
-$28M
(15.15%↑ Y/Y)
Total liabilities and
stockholders' deficit
$1,233M
(-15.08%↓ Y/Y)
Total stockholders'
deficit
-$208M
(19.07%↑ Y/Y)
Additional paid-in capital
$155M
(53.47%↑ Y/Y)
Total liabilities
$1,441M
(-15.68%↓ Y/Y)
Total current
liabilities
$868M
(-17.80%↓ Y/Y)
Long-term debt, less
current portion
$487M
(58.12%↑ Y/Y)
Accrued litigation
settlement expenses,...
$42M
(-85.95%↓ Y/Y)
Other noncurrent
liabilities
$31M
(72.22%↑ Y/Y)
Operating lease
liabilities, noncurrent
$13M
(-55.17%↓ Y/Y)
Accrued rebates and
product returns
$610M
(-13.96%↓ Y/Y)
Accounts payable and
accrued expenses
$206M
(5.10%↑ Y/Y)
Income taxes payable
$30M
(76.47%↑ Y/Y)
Accrued litigation
settlement expenses,...
$14M
(-86.67%↓ Y/Y)
Operating lease
liabilities, current
$9M
(-18.18%↓ Y/Y)
Back
Back
Balance Sheet
indivior-logo-svg
Indivior Pharmaceuticals, Inc. (INDV)
indivior-logo-svg
source: myfinsight.com
Indivior Pharmaceuticals, Inc. (INDV)